Define the validated operating window earlier
A single AI-native system from development through manufacturing, using causal models to reduce experiments while surfacing scale-up and tech transfer risk early.
98.2%
Introduction
Core capabilities across the drug lifecycle
We combine explainable, causal modeling with deep process expertise in a human-in-the-loop approach across the full lifecycle.
services
Process Development
Phase-space mapping to define the validated operating window
Simulation-led DoE to prioritize high-signal experiments
Establish robust setpoints and limits that carry into scale-up
AI Advantage
Causal simulation narrows the design space before validation work begins.
Analytical Development
Robustness profiling and qualification support
Signal-to-noise trend analysis across development and manufacturing data
Variability reduction through driver identification
AI Advantage
Isolates causal drivers from noise so methods hold up under variability.
Scale-Up & Tech Transfer
Encoded intent carried from pilot to plant
Parameter translation across scale, equipment, and sites
Early identification of scale-dependent failure modes
AI Advantage
Simulates scale constraints to quantify transfer risk and prevent late change orders.
Clinical & Commercial Manufacturing
Clinical and commercial manufacturing support
CPV and performance trending tied to key drivers
Inspection-aware updates with versioned rationale
AI Advantage
Closed-loop learning with traceable outputs for QA review and change control.
Built for First-Pass Success
Allos produces decision-ready evidence you can carry forward: validated operating windows, quantified sensitivities, and traceable rationale that ensures predictability from development through tech transfer and manufacturing.
Explainable AI applied at every stage
1
Formulation
2
Development
3
Optimization
4
Transfer
5
Manufacturing
Know what will hold up at scale
Bring your molecule, constraints, and current data. Allos maps formulation space to derive leads that remain soluble, bioavailable, and stable over time, delivering inspection-aware outputs designed for QA review and change control.
Discuss your program
Service
AI Platform
Regulatory & Quality
About us
Jobs
© 2026 Allos. All rights reserved.
Privacy Policy
Define the validated operating window earlier
A single AI-native system from development through manufacturing, using causal models to reduce experiments while surfacing scale-up and tech transfer risk early.
98.2%
Introduction
Core capabilities across the drug lifecycle
We combine explainable, causal modeling with deep process expertise in a human-in-the-loop approach across the full lifecycle.
services
Process Development
Phase-space mapping to define the validated operating window
Simulation-led DoE to prioritize high-signal experiments
Establish robust setpoints and limits that carry into scale-up
AI Advantage
Causal simulation narrows the design space before validation work begins.
Analytical Development
Robustness profiling and qualification support
Signal-to-noise trend analysis across development and manufacturing data
Variability reduction through driver identification
AI Advantage
Isolates causal drivers from noise so methods hold up under variability.
Scale-Up & Tech Transfer
Encoded intent carried from pilot to plant
Parameter translation across scale, equipment, and sites
Early identification of scale-dependent failure modes
AI Advantage
Simulates scale constraints to quantify transfer risk and prevent late change orders.
Clinical & Commercial Manufacturing
Clinical and commercial manufacturing support
CPV and performance trending tied to key drivers
Inspection-aware updates with versioned rationale
AI Advantage
Closed-loop learning with traceable outputs for QA review and change control.
Built for First-Pass Success
Allos produces decision-ready evidence you can carry forward: validated operating windows, quantified sensitivities, and traceable rationale that ensures predictability from development through tech transfer and manufacturing.
Explainable AI applied at every stage
1
Formulation
2
Development
3
Optimization
4
Transfer
5
Manufacturing
Know what will hold up at scale
Bring your molecule, constraints, and current data. Allos maps formulation space to derive leads that remain soluble, bioavailable, and stable over time, delivering inspection-aware outputs designed for QA review and change control.
Discuss your program
Define the validated operating window earlier
A single AI-native system from development through manufacturing, using causal models to reduce experiments while surfacing scale-up and tech transfer risk early.
98.2%
Introduction
Core capabilities across the drug lifecycle
We combine explainable, causal modeling with deep process expertise in a human-in-the-loop approach across the full lifecycle.
services
Process Development
Phase-space mapping to define the validated operating window
Simulation-led DoE to prioritize high-signal experiments
Establish robust setpoints and limits that carry into scale-up
AI Advantage
Causal simulation narrows the design space before validation work begins.
Analytical Development
Robustness profiling and qualification support
Signal-to-noise trend analysis across development and manufacturing data
Variability reduction through driver identification
AI Advantage
Isolates causal drivers from noise so methods hold up under variability.
Scale-Up & Tech Transfer
Encoded intent carried from pilot to plant
Parameter translation across scale, equipment, and sites
Early identification of scale-dependent failure modes
AI Advantage
Simulates scale constraints to quantify transfer risk and prevent late change orders.
Clinical & Commercial Manufacturing
Clinical and commercial manufacturing support
CPV and performance trending tied to key drivers
Inspection-aware updates with versioned rationale
AI Advantage
Closed-loop learning with traceable outputs for QA review and change control.
Built for First-Pass Success
Allos produces decision-ready evidence you can carry forward: validated operating windows, quantified sensitivities, and traceable rationale that ensures predictability from development through tech transfer and manufacturing.
Explainable AI applied at every stage
1
Formulation
2
Development
3
Optimization
4
Transfer
5
Manufacturing
Know what will hold up at scale
Bring your molecule, constraints, and current data. Allos maps formulation space to derive leads that remain soluble, bioavailable, and stable over time, delivering inspection-aware outputs designed for QA review and change control.
Discuss your program
Define the validated operating window earlier
A single AI-native system from development through manufacturing, using causal models to reduce experiments while surfacing scale-up and tech transfer risk early.
98.2%
Introduction
Core capabilities across the drug lifecycle
We combine explainable, causal modeling with deep process expertise in a human-in-the-loop approach across the full lifecycle.
services
Process Development
Phase-space mapping to define the validated operating window
Simulation-led DoE to prioritize high-signal experiments
Establish robust setpoints and limits that carry into scale-up
AI Advantage
Causal simulation narrows the design space before validation work begins.
Analytical Development
Robustness profiling and qualification support
Signal-to-noise trend analysis across development and manufacturing data
Variability reduction through driver identification
AI Advantage
Isolates causal drivers from noise so methods hold up under variability.
Scale-Up & Tech Transfer
Encoded intent carried from pilot to plant
Parameter translation across scale, equipment, and sites
Early identification of scale-dependent failure modes
AI Advantage
Simulates scale constraints to quantify transfer risk and prevent late change orders.
Clinical & Commercial Manufacturing
Clinical and commercial manufacturing support
CPV and performance trending tied to key drivers
Inspection-aware updates with versioned rationale
AI Advantage
Closed-loop learning with traceable outputs for QA review and change control.
Built for First-Pass Success
Allos produces decision-ready evidence you can carry forward: validated operating windows, quantified sensitivities, and traceable rationale that ensures predictability from development through tech transfer and manufacturing.
Explainable AI applied at every stage
1
Formulation
2
Development
3
Optimization
4
Transfer
5
Manufacturing
Know what will hold up at scale
Bring your molecule, constraints, and current data. Allos maps formulation space to derive leads that remain soluble, bioavailable, and stable over time, delivering inspection-aware outputs designed for QA review and change control.
Discuss your program
Define the validated operating window earlier
A single AI-native system from development through manufacturing, using causal models to reduce experiments while surfacing scale-up and tech transfer risk early.
98.2%
Introduction
Core capabilities across the drug lifecycle
We combine explainable, causal modeling with deep process expertise in a human-in-the-loop approach across the full lifecycle.
services
Process Development
Phase-space mapping to define the validated operating window
Simulation-led DoE to prioritize high-signal experiments
Establish robust setpoints and limits that carry into scale-up
AI Advantage
Causal simulation narrows the design space before validation work begins.
Analytical Development
Robustness profiling and qualification support
Signal-to-noise trend analysis across development and manufacturing data
Variability reduction through driver identification
AI Advantage
Isolates causal drivers from noise so methods hold up under variability.
Scale-Up & Tech Transfer
Encoded intent carried from pilot to plant
Parameter translation across scale, equipment, and sites
Early identification of scale-dependent failure modes
AI Advantage
Simulates scale constraints to quantify transfer risk and prevent late change orders.
Clinical & Commercial Manufacturing
Clinical and commercial manufacturing support
CPV and performance trending tied to key drivers
Inspection-aware updates with versioned rationale
AI Advantage
Closed-loop learning with traceable outputs for QA review and change control.
Built for First-Pass Success
Allos produces decision-ready evidence you can carry forward: validated operating windows, quantified sensitivities, and traceable rationale that ensures predictability from development through tech transfer and manufacturing.
Explainable AI applied at every stage
1
Formulation
2
Development
3
Optimization
4
Transfer
5
Manufacturing
Know what will hold up at scale
Bring your molecule, constraints, and current data. Allos maps formulation space to derive leads that remain soluble, bioavailable, and stable over time, delivering inspection-aware outputs designed for QA review and change control.
Discuss your program